Pharmaceutical companies are in the hot seat for allegedly pushing drugs for uses not approved by the government, a growing practice that has triggered a congressional investigation, litigation and hefty settlements.

Attorneys and legal experts say that scores of private and government lawsuits have been filed in the past two years, charging drug companies with illegally influencing doctors to prescribe drugs for unapproved uses — a practice known as “off-labeling.”